Key points are not available for this paper at this time.
Warm autoimmune hemolytic anemia is a chronic, relapsing disease characterized by anemia, reticulocytosis, other evidence of hemolysis, and a positive direct antiglobulin test. First-line therapy (after prompt transfusion of ABO- and RhD-matched blood in patients with severe anemia) involves glucocorticoids and rituximab.
Robert A. Brodsky (Wed,) studied this question.